Holland T C, Homa F L, Marlin S D, Levine M, Glorioso J
J Virol. 1984 Nov;52(2):566-74. doi: 10.1128/JVI.52.2.566-574.1984.
A virus-neutralizing monoclonal antibody specific for glycoprotein C (gC) of herpes simplex virus type 1 strain KOS was used to select a number of neutralization-resistant mutants. A total of 103 of these mutants also were resistant to neutralization by a pool of gC-specific antibodies and thus were operationally defined as gC-. Analysis of mutant-infected cell mRNA showed that a 2.7-kilobase mRNA, comparable in size to the wild-type gC mRNA, was produced by nearly all mutants. However, six mutants, gC-5, gC-13, gC-21, gC-39, gC-46, and gC-98, did not produce the normal-size gC mRNA but rather synthesized a novel 1.1-kilobase RNA species. These mutants had deletions of 1.6 kilobases in the coding sequence of the gC structural gene, which explains their gC- phenotype. Despite the production of an apparently normal mRNA by the remaining 97 mutants, only 7 mutants produced a detectable gC polypeptide. In contrast to wild-type gC, which is a membrane-bound glycoprotein with an apparent molecular weight of 130,000 (130K), five of these mutants quantitatively secreted proteins of lower molecular weight into the culture medium. These were synLD70 (101K), gC-8 (109K), gC-49 (112K), gC-53 (108K), and gC-85 (106K). The mutant gC-3 secreted a protein that was indistinguishable in molecular weight from wild-type KOS gC. Another mutant, gC-44, produced a gC protein which also was indistinguishable from wild-type gC by molecular weight and which remained cell associated. Pulse-labeling of infected cells in the presence and absence of the glycosylation inhibitor tunicamycin demonstrated that these proteins were glycosylated and provided estimates of the molecular weights of the nonglycosylated primary translation products. The smallest of these proteins was produced by synLD70 and was 48K, about two-thirds the size of the wild-type polypeptide precursor (73K). Physical mapping of the mutations in synLD70 and gC-8 by marker rescue placed these mutations in the middle third of the gC coding sequence. Mapping of the mutations in other gC- mutants, including two in which no protein product was detected, also placed these mutations within or very close to the gC gene. The biochemical and genetic data available on mutants secreting gC gene products suggest that secretion is due to the lack of a functional transmembrane anchor sequence on these mutant glycoproteins.
一种针对单纯疱疹病毒1型KOS株糖蛋白C(gC)的病毒中和单克隆抗体被用于筛选一些中和抗性突变体。这些突变体中共有103个也对一组gC特异性抗体的中和作用具有抗性,因此在操作上被定义为gC-。对突变体感染细胞的mRNA分析表明,几乎所有突变体都产生了一种2.7千碱基的mRNA,其大小与野生型gC mRNA相当。然而,六个突变体gC-5、gC-13、gC-21、gC-39、gC-46和gC-98并未产生正常大小的gC mRNA,而是合成了一种新的1.1千碱基的RNA种类。这些突变体在gC结构基因的编码序列中有1.6千碱基的缺失,这解释了它们的gC-表型。尽管其余97个突变体产生了明显正常的mRNA,但只有7个突变体产生了可检测到的gC多肽。与野生型gC(一种表观分子量为130,000(130K)的膜结合糖蛋白)不同,这些突变体中有五个将较低分子量的蛋白质定量分泌到培养基中。它们分别是synLD70(101K)、gC-8(109K)、gC-49(112K)、gC-53(108K)和gC-85(106K)。突变体gC-3分泌的一种蛋白质在分子量上与野生型KOS gC无法区分。另一个突变体gC-44产生的gC蛋白在分子量上也与野生型gC无法区分,并且仍与细胞相关。在有和没有糖基化抑制剂衣霉素存在的情况下对感染细胞进行脉冲标记表明,这些蛋白质是糖基化的,并提供了非糖基化初级翻译产物分子量的估计值。这些蛋白质中最小的是由synLD70产生的,为48K,约为野生型多肽前体(73K)大小的三分之二。通过标记拯救对synLD70和gC-8中的突变进行物理图谱分析,将这些突变定位在gC编码序列的中间三分之一处。对其他gC-突变体(包括两个未检测到蛋白质产物的突变体)中的突变进行图谱分析,也将这些突变定位在gC基因内或非常接近gC基因的位置。关于分泌gC基因产物的突变体的生化和遗传数据表明,分泌是由于这些突变体糖蛋白上缺乏功能性跨膜锚定序列所致。